Literature DB >> 8525795

Evidence of persistent blood-brain barrier abnormalities in chronic-progressive multiple sclerosis.

L Claudio1, C S Raine, C F Brosnan.   

Abstract

Brain capillaries were analyzed morphometrically for alterations in organelle distribution and density in biopsy samples of central nervous system tissue from seven patients diagnosed as having chronic progressive multiple sclerosis. Data were expressed as percentage of endothelial cytoplasm occupied by the respective organelles. The density of pinocytotic vesicles in endothelium ranged from 0.53% within normal-appearing parenchyma to 1.2% in gliotic areas. For mitochondria the values ranged from 10.87% in normal areas to 4.72% in the same respective samples. Thus, an inverse correlation between vesicular and mitochondrial content was observed. These findings suggest that endothelial cells in gliotic areas are similar to endothelial cells of the systemic circulation in their mitochondrial content and pinocytotic activity. Interendothelial junctions in capillaries of all areas examined appeared normal. Additional evidence for a continuous blood-brain barrier anomaly in multiple sclerosis was the accumulation of perivascular fibrin, suggesting an increase in microvascular permeability. Perivascular collagen deposits, degenerative changes in pericytes and astrocytic swelling were also indicators of an increase in blood-brain barrier permeability. Taken together with previous data from experimental autoimmune encephalomyelitis, the present findings in chronic silent multiple sclerosis lesions suggest that central nervous system endothelial cells show persistent abnormalities of the blood-brain barrier, even in the absence of active inflammation.

Entities:  

Mesh:

Year:  1995        PMID: 8525795     DOI: 10.1007/bf00296505

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  52 in total

1.  Blood-brain barrier damage in acute multiple sclerosis plaques. An immunocytological study.

Authors:  D Gay; M Esiri
Journal:  Brain       Date:  1991-02       Impact factor: 13.501

2.  The longstanding MS lesion. A quantitative MRI and electron microscopic study.

Authors:  D Barnes; P M Munro; B D Youl; J W Prineas; W I McDonald
Journal:  Brain       Date:  1991-06       Impact factor: 13.501

Review 3.  Warner-Lambert/Parke-Davis award lecture. Cytokine-mediated activation of vascular endothelium. Physiology and pathology.

Authors:  J S Pober
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

4.  Patterns of blood-brain barrier impairment and clinical features in multiple sclerosis.

Authors:  B N McLean; A Z Zeman; D Barnes; E J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-04       Impact factor: 10.154

5.  Increased vesicular transport and decreased mitochondrial content in blood-brain barrier endothelial cells during experimental autoimmune encephalomyelitis.

Authors:  L Claudio; Y Kress; W T Norton; C F Brosnan
Journal:  Am J Pathol       Date:  1989-12       Impact factor: 4.307

6.  Blood-brain barrier permeability of human gliomas as determined by quantitation of cytoplasmic vesicles of the capillary endothelium and scintigraphic findings.

Authors:  S Kohn; D Front; I Nir
Journal:  Cancer Invest       Date:  1989       Impact factor: 2.176

7.  Quantitative study of microvessel ultrastructure in human peritumoral brain tissue. Evidence for a blood-brain barrier defect.

Authors:  P A Stewart; K Hayakawa; C L Farrell; R F Del Maestro
Journal:  J Neurosurg       Date:  1987-11       Impact factor: 5.115

8.  Oligodendrocytes in the early course of multiple sclerosis.

Authors:  W Brück; M Schmied; G Suchanek; Y Brück; H Breitschopf; S Poser; S Piddlesden; H Lassmann
Journal:  Ann Neurol       Date:  1994-01       Impact factor: 10.422

9.  Ultrastructural studies of the blood-retina barrier after exposure to interleukin-1 beta or tumor necrosis factor-alpha.

Authors:  L Claudio; J A Martiney; C F Brosnan
Journal:  Lab Invest       Date:  1994-06       Impact factor: 5.662

10.  Injury-related spinal cord astrocytes are immunoglobulin-positive (IgM and/or IgG) at different time periods in the regenerative process.

Authors:  J J Bernstein; W J Goldberg
Journal:  Brain Res       Date:  1987-11-17       Impact factor: 3.252

View more
  53 in total

1.  Enhancing patterns in multiple sclerosis: evolution and persistence.

Authors:  J He; R I Grossman; Y Ge; L J Mannon
Journal:  AJNR Am J Neuroradiol       Date:  2001-04       Impact factor: 3.825

Review 2.  The multiple sclerosis degradome: enzymatic cascades in development and progression of central nervous system inflammatory disease.

Authors:  I A Scarisbrick
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

Review 3.  Mechanisms and implications of adaptive immune responses after traumatic spinal cord injury.

Authors:  D P Ankeny; P G Popovich
Journal:  Neuroscience       Date:  2008-07-04       Impact factor: 3.590

4.  Roles for thrombin and fibrin(ogen) in cytokine/chemokine production and macrophage adhesion in vivo.

Authors:  Frank M Szaba; Stephen T Smiley
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

5.  Variations in mitochondrial DNA copy numbers in MS brains.

Authors:  Andrei Blokhin; Tamara Vyshkina; Samuel Komoly; Bernadette Kalman
Journal:  J Mol Neurosci       Date:  2008-06-20       Impact factor: 3.444

Review 6.  Cytokine-induced inflammation in the central nervous system revisited.

Authors:  J A Martiney; C Cuff; M Litwak; J Berman; C F Brosnan
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

Review 7.  Pathophysiology of the blood-brain barrier.

Authors:  K Selmaj
Journal:  Springer Semin Immunopathol       Date:  1996

8.  Thrombin mutant W215A/E217A treatment improves neurological outcome and attenuates central nervous system damage in experimental autoimmune encephalomyelitis.

Authors:  Norah G Verbout; Xiaolin Yu; Laura D Healy; Kevin G Phillips; Erik I Tucker; András Gruber; Owen J T McCarty; Halina Offner
Journal:  Metab Brain Dis       Date:  2014-05-09       Impact factor: 3.584

9.  Endothelial cell integrin laminin receptor expression in multiple sclerosis lesions.

Authors:  R A Sobel; J R Hinojoza; A Maeda; M Chen
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

10.  The neuregulin, glial growth factor 2, diminishes autoimmune demyelination and enhances remyelination in a chronic relapsing model for multiple sclerosis.

Authors:  B Cannella; C J Hoban; Y L Gao; R Garcia-Arenas; D Lawson; M Marchionni; D Gwynne; C S Raine
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.